These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7224706)

  • 1. Bioavailability of propranolol in the dog.
    Tse FL; Sanders TM; Reo JP
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):180-9. PubMed ID: 7224706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of phenobarbital with propranolol in the dog. 2. Bioavailability, metabolism and pharmacokinetics.
    Vu VT; Bai SA; Abramson FP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):55-61. PubMed ID: 6848749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective oral bioavailability of (+/-)-propranolol in the dog. A GC-MS study using a stable isotope technique.
    Walle T; Walle UK
    Res Commun Chem Pathol Pharmacol; 1979 Mar; 23(3):453-64. PubMed ID: 461970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselective increase in propranolol bioavailability during chronic dosing in the dog.
    Bai SA; Wilson MJ; Walle UK; Walle T
    J Pharmacol Exp Ther; 1983 Nov; 227(2):360-4. PubMed ID: 6631718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
    Bialer M; Wu WH; Look ZM; Silber BM; Yacobi A
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):21-32. PubMed ID: 3589152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of propranolol: a review.
    Shand DG
    Postgrad Med J; 1976; 52 Suppl 4():22-25. PubMed ID: 787953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of food on the intravenous and oral dose kinetics of propranolol in the dog.
    Bai SA; Walle UK; Walle T
    J Pharmacokinet Biopharm; 1985 Jun; 13(3):229-41. PubMed ID: 4087163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No stereoselective first-pass hepatic extraction of propranolol.
    Jackman GP; McLean AJ; Jennings GL; Bobik A
    Clin Pharmacol Ther; 1981 Sep; 30(3):291-6. PubMed ID: 7273593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presystemic and systemic glucuronidation of propranolol.
    Walle T; Fagan TC; Conradi EC; Walle UK; Gaffney TE
    Clin Pharmacol Ther; 1979 Aug; 26(2):167-72. PubMed ID: 455886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and systemic bioavailability of menogaril, an anthracycline antitumor agent, in the mouse, dog, and monkey.
    Adams WJ; McGovren JP; Dalm EA; Brewer JE; Hosley JD
    Cancer Res; 1989 Nov; 49(22):6328-36. PubMed ID: 2529962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of nipradilol (K-351), a new antihypertensive agent. II. Influence of the route of administration on bioavailability in dogs.
    Yoshimura M; Kojima J; Ito T; Fujii M; Suzuki J
    J Pharmacobiodyn; 1985 Jul; 8(7):503-12. PubMed ID: 4067813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of HIV protease inhibitor DMP 323 in rats and dogs.
    Grubb MF; Wong YN; Burcham DL; Saxton PL; Quon CY; Huang SM
    Drug Metab Dispos; 1994; 22(5):709-12. PubMed ID: 7835221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and metabolism of a 4'-methylthio derivative of propranolol in the dog.
    Bai SA; Easterling DE; Wilson MJ; Walle UK; Haney CA; Peet NP; Pruett JK; Walle T
    Drug Metab Dispos; 1989; 17(5):495-505. PubMed ID: 2573492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of route of administration and biliary excretion on the pharmacokinetics of isotretinoin in the dog.
    Cotler S; Chen S; Macasieb T; Colburn WA
    Drug Metab Dispos; 1984; 12(2):143-7. PubMed ID: 6144477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
    Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modipafant, a new PAF antagonist: pharmacokinetics and disposition in rat, dog and man.
    Jezequel SG; Uden S; Wastall P
    Xenobiotica; 1996 Sep; 26(9):963-75. PubMed ID: 8893043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of propranolol on the disposition and negative dromotropic activity of diltiazem in the dog during multiple dosing.
    Maskasame C; Lankford SM; Bai SA
    Drug Metab Dispos; 1993; 21(1):156-61. PubMed ID: 8095211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of barnidipine hydrochloride, a new dihydropyridine calcium channel blocker, in the rat, dog and human.
    Teramura T; Watanabe T; Higuchi S; Hashimoto K
    Xenobiotica; 1995 Nov; 25(11):1237-46. PubMed ID: 8592872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of portasystemic anastomoses in childhood on propranolol pharmacokinetics].
    Cario WR; Glende M; Lampe D; Buchali K; Bürger K; Grossmann P; Huth M; Rüstow B; Zimmermann HB
    Schweiz Med Wochenschr; 1981 Jul; 111(29):1088-93. PubMed ID: 7268362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.